
Conference Coverage
Latest Content

Peer Support Helps Black Women With Endometrial Cancer Stay on Treatment

Evolving Roles in Gynecologic Oncology: Balancing Surgery, Systemic Therapy and Team-Based Care

Real-World ADC Data Support Use in More Diverse Patients

Verzenio Plus Letrozole Shows Durable Responses in Advanced Endometrial Cancer

Avutometinib Plus Defactinib Shows Lasting Benefit in LGSOC

Shorts










Podcasts
Videos
All News

Learn what an invasive breast cancer diagnosis means and explore treatment options, including surgery and targeted therapy, in this patient education guide.


An expert highlights global barriers to cancer care and outlines solutions to improve access, education and equity for patients worldwide.

Dr. Sheri Prentiss shares how early detection and patient advocacy can prevent chronic lymphedema and improve quality of life for cancer survivors.

An oncology social worker discusses the unique psychosocial challenges younger adults face during cancer treatment and survivorship.

Survivor Kiana Wooten shares her story on genetic testing, overcoming sepsis and why choosing to stay flat was her most empowering medical decision.

My smile today is one of compassion. It’s a smile that welcomes the stranger I meet. It radiates joy and presence.

New EGFR-targeting combos may improve response rates and durability for patients with head and neck cancer.

Breast cancer survivor Dr. Sheri Prentiss discusses shifting oncology care from a "wait and see" approach to early lymphedema intervention and advocacy.

Experts highlight the need for tailored care strategies to address fertility, financial strain and survivorship challenges in younger adults with cancer.

Dr. Alexander Meves explains how the Merlin CP-GEP test uses molecular data to help melanoma patients safely avoid unnecessary lymph node surgeries.

A tongue cancer survivor and her oncologist discuss lasting side effects, daily management, self-advocacy and emerging treatment approaches.

Pediatric Cancer Research Foundation CEO Danielle Fragalla discusses the biological differences in pediatric cancer and the need for treatments designed for developing bodies.

Gotistobart reduced risk of death by 54% and doubled 12-month survival vs chemotherapy in advanced squamous NSCLC after prior treatment.

A newly approved all-oral combination for CLL offers patients a fixed-duration option, reducing clinic visits and expanding personalized care.













